View Financial HealthFDC 배당 및 자사주 매입배당 기준 점검 3/6FDC 수익으로 충분히 충당되는 현재 수익률 1.34% 보유한 배당금 지급 회사입니다.핵심 정보1.3%배당 수익률n/a자사주 매입 수익률총 주주 수익률n/a미래 배당 수익률n/a배당 성장률10.8%다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향38%최근 배당 및 자사주 매입 업데이트Upcoming Dividend • Nov 15Upcoming dividend of ₹5.00 per shareEligible shareholders must have bought the stock before 22 November 2024. Payment date: 06 December 2024. Payout ratio is a comfortable 26% and this is well supported by cash flows. Trailing yield: 2.0%. Within top quartile of Indian dividend payers (1.2%). Higher than average of industry peers (0.7%).모든 업데이트 보기Recent updatesReported Earnings • Feb 07Third quarter 2026 earnings released: EPS: ₹1.74 (vs ₹2.28 in 3Q 2025)Third quarter 2026 results: EPS: ₹1.74 (down from ₹2.28 in 3Q 2025). Revenue: ₹4.86b (up 4.6% from 3Q 2025). Net income: ₹283.0m (down 24% from 3Q 2025). Profit margin: 5.8% (down from 8.0% in 3Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has increased by 12% per year, which means it is tracking significantly ahead of earnings growth.Reported Earnings • Nov 06Second quarter 2026 earnings releasedSecond quarter 2026 results: Revenue: ₹4.94b (down 3.9% from 2Q 2025). Net income: ₹283.7m (down 61% from 2Q 2025). Profit margin: 5.7% (down from 14% in 2Q 2025). The decrease in margin was primarily driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has only increased by 12% per year, which means it is significantly lagging earnings growth.공시 • Oct 20+ 1 more updateFDC Limited Announces CFO ChangesFDC Limited informed Mr. Vijay Dharmadatt Bhatt has resigned from the position of Chief Financial Officer (CFO) of the Company in order to pursue better prospects. The Board of Directors, at its meeting held on October 17, 2025, noted and accepted his resignation. Mr. Vijay D. Bhatt will be relieved from the responsibility of CFO after the close of business hours on October 20, 2025. The company further informed that based on the recommendation of the Nomination and Remuneration Committee and the Audit Committee, the Board of Directors of the Company have at its meeting held on October 17, 2025, approved the appointment of Mr. Vishal Shah as the Chief Financial Officer with effect from 24th October, 2025. Mr. Vishal Shah has about 20 years of work experience with an established track record of handling diverse finance portfolios like Business Finance, Costing, Financial Reporting and Treasury in the pharmaceutical industry.분석 기사 • Sep 19We Think FDC Limited's (NSE:FDC) CEO Compensation Looks FairKey Insights FDC to hold its Annual General Meeting on 25th of September Total pay for CEO Nandan Chandavarkar includes...공시 • Aug 29+ 2 more updatesFDC Limited to Report Q2, 2026 Results on Nov 05, 2025FDC Limited announced that they will report Q2, 2026 results on Nov 05, 2025공시 • Aug 26FDC Limited, Annual General Meeting, Sep 25, 2025FDC Limited, Annual General Meeting, Sep 25, 2025, at 10:00 Indian Standard Time.Reported Earnings • Aug 08First quarter 2026 earnings released: EPS: ₹7.45 (vs ₹7.31 in 1Q 2025)First quarter 2026 results: EPS: ₹7.45 (up from ₹7.31 in 1Q 2025). Revenue: ₹6.84b (up 7.2% from 1Q 2025). Net income: ₹1.21b (up 1.9% from 1Q 2025). Profit margin: 18% (in line with 1Q 2025). Over the last 3 years on average, earnings per share has increased by 18% per year whereas the company’s share price has increased by 21% per year.공시 • Aug 02FDC Limited to Report Q1, 2026 Results on Aug 07, 2025FDC Limited announced that they will report Q1, 2026 results on Aug 07, 2025분석 기사 • Jul 01A Look At The Fair Value Of FDC Limited (NSE:FDC)Key Insights Using the 2 Stage Free Cash Flow to Equity, FDC fair value estimate is ₹506 Current share price of ₹488...분석 기사 • May 31FDC Limited's (NSE:FDC) Price Is Out Of Tune With EarningsThere wouldn't be many who think FDC Limited's ( NSE:FDC ) price-to-earnings (or "P/E") ratio of 26.7x is worth a...Reported Earnings • May 29Full year 2025 earnings released: EPS: ₹16.39 (vs ₹18.59 in FY 2024)Full year 2025 results: EPS: ₹16.39 (down from ₹18.59 in FY 2024). Revenue: ₹22.0b (up 13% from FY 2024). Net income: ₹2.67b (down 13% from FY 2024). Profit margin: 12% (down from 16% in FY 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 19% per year whereas the company’s share price has increased by 21% per year.공시 • May 22FDC Limited to Report Q4, 2025 Results on May 28, 2025FDC Limited announced that they will report Q4, 2025 results on May 28, 2025Reported Earnings • Feb 14Third quarter 2025 earnings released: EPS: ₹2.28 (vs ₹4.86 in 3Q 2024)Third quarter 2025 results: EPS: ₹2.28 (down from ₹4.86 in 3Q 2024). Revenue: ₹4.64b (up 1.3% from 3Q 2024). Net income: ₹370.4m (down 53% from 3Q 2024). Profit margin: 8.0% (down from 17% in 3Q 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth.Buy Or Sell Opportunity • Feb 10Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 7.6% to ₹461. The fair value is estimated to be ₹586, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 14%.공시 • Feb 07FDC Limited to Report Q3, 2025 Results on Feb 12, 2025FDC Limited announced that they will report Q3, 2025 results on Feb 12, 2025Buy Or Sell Opportunity • Jan 22Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 9.9% to ₹466. The fair value is estimated to be ₹586, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 14%.공시 • Dec 19FDC Limited Receives Final Approval from US FDA for the Company's Abbreviated New Drug Application for Cefixime 400 mg TabletsFDC Limited announced that the Company has received final approval from US FDA for the Company's Abbreviated New Drug Application (ANDA) for Cefixime 400 mg Tablets.Upcoming Dividend • Nov 15Upcoming dividend of ₹5.00 per shareEligible shareholders must have bought the stock before 22 November 2024. Payment date: 06 December 2024. Payout ratio is a comfortable 26% and this is well supported by cash flows. Trailing yield: 2.0%. Within top quartile of Indian dividend payers (1.2%). Higher than average of industry peers (0.7%).분석 기사 • Nov 08Estimating The Fair Value Of FDC Limited (NSE:FDC)Key Insights FDC's estimated fair value is ₹583 based on 2 Stage Free Cash Flow to Equity FDC's ₹519 share price...Reported Earnings • Nov 07Second quarter 2025 earnings released: EPS: ₹4.43 (vs ₹4.22 in 2Q 2024)Second quarter 2025 results: EPS: ₹4.43 (up from ₹4.22 in 2Q 2024). Revenue: ₹5.49b (up 13% from 2Q 2024). Net income: ₹720.4m (up 3.2% from 2Q 2024). Profit margin: 13% (down from 14% in 2Q 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 14% per year whereas the company’s share price has increased by 18% per year.공시 • Oct 29FDC Limited to Report Q2, 2025 Results on Nov 06, 2024FDC Limited announced that they will report Q2, 2025 results on Nov 06, 2024분석 기사 • Sep 20Why We Think FDC Limited's (NSE:FDC) CEO Compensation Is Not Excessive At AllKey Insights FDC will host its Annual General Meeting on 26th of September Total pay for CEO Nandan Chandavarkar...분석 기사 • Sep 13There's Reason For Concern Over FDC Limited's (NSE:FDC) Massive 30% Price JumpThe FDC Limited ( NSE:FDC ) share price has done very well over the last month, posting an excellent gain of 30...공시 • Sep 06FDC Limited Announces Cessation of CA Swati Sandesh Mayekar as Non-Independent DirectorFDC Limited announced that CA. Swati Sandesh Mayekar Non-Executive Independent Director of the Company have completed her tenure viz. second term of five (5) consecutive years on September 05, 2024 Consequently, she ceases to be the Independent Director of the company, accordingly she also ceases to be the member of various Board committees with effect from 06 September 2024.공시 • Aug 28FDC Limited, Annual General Meeting, Sep 26, 2024FDC Limited, Annual General Meeting, Sep 26, 2024, at 10:00 Indian Standard Time.분석 기사 • Aug 27Here's Why We Think FDC (NSE:FDC) Might Deserve Your Attention TodayFor beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...Reported Earnings • Aug 08First quarter 2025 earnings released: EPS: ₹7.31 (vs ₹6.62 in 1Q 2024)First quarter 2025 results: EPS: ₹7.31 (up from ₹6.62 in 1Q 2024). Revenue: ₹6.67b (up 24% from 1Q 2024). Net income: ₹1.19b (up 8.3% from 1Q 2024). Profit margin: 18% (down from 21% in 1Q 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 6% per year whereas the company’s share price has increased by 11% per year.공시 • Jul 26FDC Limited to Report Q1, 2025 Results on Aug 07, 2024FDC Limited announced that they will report Q1, 2025 results on Aug 07, 2024분석 기사 • Jul 04There Is A Reason FDC Limited's (NSE:FDC) Price Is UndemandingFDC Limited's ( NSE:FDC ) price-to-earnings (or "P/E") ratio of 26.5x might make it look like a buy right now compared...Reported Earnings • May 30Full year 2024 earnings released: EPS: ₹18.58 (vs ₹11.67 in FY 2023)Full year 2024 results: EPS: ₹18.58 (up from ₹11.67 in FY 2023). Revenue: ₹20.4b (up 15% from FY 2023). Net income: ₹3.05b (up 57% from FY 2023). Profit margin: 15% (up from 11% in FY 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 2% per year but the company’s share price has increased by 11% per year, which means it is well ahead of earnings.공시 • May 03FDC Limited Announces Board Completion of Tenure of Independent DirectorsFDC Limited announced that took note of the Completion of tenure of Independent Directors of the Company, namely, Ms. Usha Athreya Chandrasekhar and Mr. Melarkode Ganesan Parameswaran on May 9, 2024.분석 기사 • Mar 02FDC Limited's (NSE:FDC) Price Is Right But Growth Is LackingWhen close to half the companies in India have price-to-earnings ratios (or "P/E's") above 32x, you may consider FDC...Reported Earnings • Feb 08Third quarter 2024 earnings released: EPS: ₹4.86 (vs ₹2.45 in 3Q 2023)Third quarter 2024 results: EPS: ₹4.86 (up from ₹2.45 in 3Q 2023). Revenue: ₹4.83b (up 18% from 3Q 2023). Net income: ₹792.3m (up 95% from 3Q 2023). Profit margin: 16% (up from 10.0% in 3Q 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 9% per year but the company’s share price has increased by 16% per year, which means it is well ahead of earnings.Reported Earnings • Nov 09Second quarter 2024 earnings released: EPS: ₹4.22 (vs ₹3.10 in 2Q 2023)Second quarter 2024 results: EPS: ₹4.22 (up from ₹3.10 in 2Q 2023). Revenue: ₹5.14b (up 15% from 2Q 2023). Net income: ₹698.2m (up 35% from 2Q 2023). Profit margin: 14% (up from 12% in 2Q 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 16% per year but the company’s share price has increased by 5% per year, which means it is well ahead of earnings.분석 기사 • Sep 21Here's Why FDC Limited's (NSE:FDC) CEO May Have Their Pay Bumped UpKey Insights FDC to hold its Annual General Meeting on 27th of September CEO Nandan Chandavarkar's total compensation...분석 기사 • Sep 15FDC (NSE:FDC) Seems To Use Debt Quite SensiblySome say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...공시 • Sep 05+ 2 more updatesFDC Limited to Report Fiscal Year 2024 Results on May 29, 2024FDC Limited announced that they will report fiscal year 2024 results on May 29, 2024공시 • Aug 31FDC Limited, Annual General Meeting, Sep 27, 2023FDC Limited, Annual General Meeting, Sep 27, 2023, at 10:00 Indian Standard Time.공시 • Aug 10+ 1 more updateFDC Limited (BSE:531599) agreed to acquire remaining 7% stake in Fair Deal Corporation Pharmaceutical SA (Pty) Ltd. from other existing shareholders.FDC Limited (BSE:531599) agreed to acquire remaining 7% stake in Fair Deal Corporation Pharmaceutical SA (Pty) Ltd. from other existing shareholders on July 13, 2023. The consideration for this transaction will be paid in cash with settlement of their existing outstanding loan with interest. Post completion of this transaction Fair Deal Corporation Pharmaceutical SA (Pty) Ltd will become the wholly owned subsidiary of FDC Limited. Fair Deal Corporation Pharmaceutical SA (Pty) Ltd generated the revenue of ZAR 11.9 million for the year ended March 31, 2023. The transaction has been approved by the Audit Committee and Board of Directors of FDC Limited. The deal is subject to necessary approvals and regulatory compliances.New Risk • Aug 10New major risk - Revenue and earnings growthEarnings have declined by 1.1% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. This is currently the only risk that has been identified for the company.Reported Earnings • Aug 10First quarter 2024 earnings released: EPS: ₹6.62 (vs ₹4.23 in 1Q 2023)First quarter 2024 results: EPS: ₹6.62 (up from ₹4.23 in 1Q 2023). Revenue: ₹5.66b (up 14% from 1Q 2023). Net income: ₹1.10b (up 55% from 1Q 2023). Profit margin: 19% (up from 14% in 1Q 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 18% per year but the company’s share price has increased by 8% per year, which means it is well ahead of earnings.공시 • Aug 03FDC Limited to Report Q1, 2024 Results on Aug 09, 2023FDC Limited announced that they will report Q1, 2024 results on Aug 09, 2023Reported Earnings • May 30Full year 2023 earnings released: EPS: ₹11.66 (vs ₹12.82 in FY 2022)Full year 2023 results: EPS: ₹11.66 (down from ₹12.82 in FY 2022). Revenue: ₹18.3b (up 20% from FY 2022). Net income: ₹1.94b (down 10% from FY 2022). Profit margin: 11% (down from 14% in FY 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 16% per year but the company’s share price has increased by 5% per year, which means it is well ahead of earnings.Reported Earnings • Feb 10Third quarter 2023 earnings released: EPS: ₹2.45 (vs ₹2.11 in 3Q 2022)Third quarter 2023 results: EPS: ₹2.45 (up from ₹2.11 in 3Q 2022). Revenue: ₹4.28b (up 25% from 3Q 2022). Net income: ₹407.5m (up 14% from 3Q 2022). Profit margin: 9.5% (in line with 3Q 2022). Revenue is forecast to grow 21% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Pharmaceuticals industry in India. Over the last 3 years on average, earnings per share has fallen by 11% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings.공시 • Feb 01FDC Limited to Report Q3, 2023 Results on Feb 09, 2023FDC Limited announced that they will report Q3, 2023 results on Feb 09, 2023Reported Earnings • Nov 18Second quarter 2023 earnings released: EPS: ₹3.10 (vs ₹4.28 in 2Q 2022)Second quarter 2023 results: EPS: ₹3.10 (down from ₹4.28 in 2Q 2022). Revenue: ₹4.45b (up 12% from 2Q 2022). Net income: ₹518.4m (down 28% from 2Q 2022). Profit margin: 12% (down from 18% in 2Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 20% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Pharmaceuticals industry in India. Over the last 3 years on average, earnings per share has fallen by 3% per year but the company’s share price has increased by 14% per year, which means it is well ahead of earnings.Price Target Changed • Nov 16Price target increased to ₹375Up from ₹350, the current price target is provided by 1 analyst. New target price is 32% above last closing price of ₹285. Stock is down 3.3% over the past year. The company is forecast to post earnings per share of ₹20.60 for next year compared to ₹12.82 last year.분석 기사 • Sep 16Here's Why FDC Limited's (NSE:FDC) CEO Compensation Is The Least Of Shareholders' ConcernsCEO Nandan Chandavarkar has done a decent job of delivering relatively good performance at FDC Limited ( NSE:FDC...공시 • Aug 30FDC Limited to Report Q4, 2023 Results on May 23, 2023FDC Limited announced that they will report Q4, 2023 results on May 23, 2023Reported Earnings • Aug 05First quarter 2023 earnings released: EPS: ₹4.23 (vs ₹5.80 in 1Q 2022)First quarter 2023 results: EPS: ₹4.23 (down from ₹5.80 in 1Q 2022). Revenue: ₹5.14b (up 15% from 1Q 2022). Net income: ₹707.4m (down 28% from 1Q 2022). Profit margin: 14% (down from 22% in 1Q 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has increased by 18% per year, which means it is tracking significantly ahead of earnings growth.Recent Insider Transactions • Jun 11Board Member recently bought ₹912k worth of stockOn the 8th of June, Melarkode Parameswaran bought around 4k shares on-market at roughly ₹247 per share. This was the largest purchase by an insider in the last 3 months. This was the only on-market transaction from insiders over the last 12 months.Board Change • Jun 02Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 7 experienced directors. 3 highly experienced directors. Additional Non-Executive & Independent Director Ambi Parameswaran was the last director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.Reported Earnings • May 27Full year 2022 earnings: EPS and revenues miss analyst expectationsFull year 2022 results: EPS: ₹12.81 (down from ₹17.73 in FY 2021). Net income: ₹2.16b (down 28% from FY 2021). Revenue missed analyst estimates by 3.1%. Earnings per share (EPS) also missed analyst estimates by 27%. Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has only increased by 8% per year, which means it is significantly lagging earnings growth.분석 기사 • May 13A Look At The Intrinsic Value Of FDC Limited (NSE:FDC)In this article we are going to estimate the intrinsic value of FDC Limited ( NSE:FDC ) by projecting its future cash...Price Target Changed • Apr 27Price target decreased to ₹415Down from ₹460, the current price target is provided by 1 analyst. New target price is 52% above last closing price of ₹273. Stock is down 12% over the past year. The company is forecast to post earnings per share of ₹17.60 for next year compared to ₹17.73 last year.Reported Earnings • Feb 10Third quarter 2022 earnings: EPS and revenues miss analyst expectationsThird quarter 2022 results: EPS: ₹2.11 (down from ₹4.45 in 3Q 2021). Revenue: ₹3.55b (up 4.2% from 3Q 2021). Net income: ₹356.9m (down 53% from 3Q 2021). Profit margin: 10% (down from 22% in 3Q 2021). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 9.5%. Earnings per share (EPS) also missed analyst estimates by 7.7%. Over the next year, revenue is forecast to grow 22%, compared to a 13% growth forecast for the industry in India. Over the last 3 years on average, earnings per share has increased by 20% per year whereas the company’s share price has increased by 24% per year.분석 기사 • Nov 18Weak Statutory Earnings May Not Tell The Whole Story For FDC (NSE:FDC)The subdued market reaction suggests that FDC Limited's ( NSE:FDC ) recent earnings didn't contain any surprises. We...Reported Earnings • Nov 16Second quarter 2022 earnings released: EPS ₹4.28 (vs ₹5.15 in 2Q 2021)The company reported a soft second quarter result with weaker earnings and profit margins, although revenues improved. Second quarter 2022 results: Revenue: ₹3.98b (up 7.1% from 2Q 2021). Net income: ₹724.0m (down 18% from 2Q 2021). Profit margin: 18% (down from 24% in 2Q 2021). The decrease in margin was driven by higher expenses.Price Target Changed • Nov 16Price target decreased to ₹415Down from ₹470, the current price target is provided by 1 analyst. New target price is 40% above last closing price of ₹297. Stock is down 8.7% over the past year. The company is forecast to post earnings per share of ₹20.80 for next year compared to ₹17.73 last year.분석 기사 • Aug 20Here's Why I Think FDC (NSE:FDC) Is An Interesting StockIt's only natural that many investors, especially those who are new to the game, prefer to buy shares in 'sexy' stocks...Reported Earnings • Aug 18First quarter 2022 earnings released: EPS ₹5.80 (vs ₹5.36 in 1Q 2021)The company reported a solid first quarter result with improved earnings and revenues, although profit margins were weaker. First quarter 2022 results: Revenue: ₹4.47b (up 45% from 1Q 2021). Net income: ₹978.7m (up 6.7% from 1Q 2021). Profit margin: 22% (down from 30% in 1Q 2021). The decrease in margin was driven by higher expenses.Valuation Update With 7 Day Price Move • Jun 16Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₹394, the stock trades at a forward P/E ratio of 18x. Average forward P/E is 26x in the Pharmaceuticals industry in India. Total returns to shareholders of 63% over the past three years.분석 기사 • May 29FDC Limited (NSE:FDC) Just Recorded An Earnings Miss And Analysts Are Updating Their NumbersFDC Limited ( NSE:FDC ) missed earnings with its latest full-year results, disappointing overly-optimistic forecasts...Reported Earnings • May 28Full year 2021 earnings released: EPS ₹17.72 (vs ₹13.94 in FY 2020)The company reported a decent full year result with improved earnings and profit margins, although revenues were flat. Full year 2021 results: Revenue: ₹13.3b (flat on FY 2020). Net income: ₹3.01b (up 26% from FY 2020). Profit margin: 23% (up from 18% in FY 2020). Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has only increased by 12% per year, which means it is significantly lagging earnings growth.분석 기사 • Apr 30Here's Why We Think FDC (NSE:FDC) Is Well Worth WatchingFor beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...분석 기사 • Mar 11What Percentage Of FDC Limited (NSE:FDC) Shares Do Insiders Own?The big shareholder groups in FDC Limited ( NSE:FDC ) have power over the company. Generally speaking, as a company...분석 기사 • Feb 21If You Had Bought FDC (NSE:FDC) Shares Five Years Ago You'd Have Earned 63% ReturnsIt hasn't been the best quarter for FDC Limited ( NSE:FDC ) shareholders, since the share price has fallen 10% in that...Price Target Changed • Feb 10Price target raised to ₹470Up from ₹425, the current price target is an average from 2 analysts. The new target price is 69% above the current share price of ₹278. As of last close, the stock is up 10% over the past year.분석 기사 • Feb 06Declining Stock and Solid Fundamentals: Is The Market Wrong About FDC Limited (NSE:FDC)?It is hard to get excited after looking at FDC's (NSE:FDC) recent performance, when its stock has declined 13% over the...Reported Earnings • Feb 05Third quarter 2021 earnings released: EPS ₹4.47 (vs ₹4.31 in 3Q 2020)The company reported a solid third quarter result with improved earnings and revenues, although profit margins were weaker. Third quarter 2021 results: Revenue: ₹3.75b (up 17% from 3Q 2020). Net income: ₹752.5m (up 1.5% from 3Q 2020). Profit margin: 20% (down from 23% in 3Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 27% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.Is New 90 Day High Low • Feb 05New 90-day low: ₹288The company is down 13% from its price of ₹332 on 06 November 2020. The Indian market is up 23% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Pharmaceuticals industry, which is up 9.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₹147 per share.Is New 90 Day High Low • Jan 21New 90-day low: ₹312The company is down 10.0% from its price of ₹347 on 23 October 2020. The Indian market is up 24% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Pharmaceuticals industry, which is up 10.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₹89.28 per share.분석 기사 • Jan 19With EPS Growth And More, FDC (NSE:FDC) Is InterestingFor beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...분석 기사 • Dec 29FDC Limited (NSE:FDC) Has Got What It Takes To Be An Attractive Dividend StockIs FDC Limited ( NSE:FDC ) a good dividend stock? How can we tell? Dividend paying companies with growing earnings can...분석 기사 • Dec 08Could The FDC Limited (NSE:FDC) Ownership Structure Tell Us Something Useful?The big shareholder groups in FDC Limited ( NSE:FDC ) have power over the company. Institutions will often hold stock...분석 기사 • Nov 12The FDC (NSE:FDC) Share Price Has Gained 79% And Shareholders Are Hoping For MoreThe simplest way to invest in stocks is to buy exchange traded funds. But investors can boost returns by picking...Reported Earnings • Nov 10Second quarter 2021 earnings released: EPS ₹5.15The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: ₹3.90b (up 13% from 2Q 2020). Net income: ₹880.8m (up 63% from 2Q 2020). Profit margin: 23% (up from 16% in 2Q 2020). The increase in margin was driven by higher revenue.Analyst Estimate Surprise Post Earnings • Nov 10Revenue and earnings beat expectationsRevenue exceeded analyst estimates by 14%. Earnings per share (EPS) also surpassed analyst estimates by 22%. Over the next year, revenue is forecast to grow 16%, compared to a 12% growth forecast for the Pharmaceuticals industry in India.분석 기사 • Oct 22Is FDC Limited's (NSE:FDC) Latest Stock Performance A Reflection Of Its Financial Health?FDC's (NSE:FDC) stock is up by a considerable 27% over the past three months. Given that the market rewards strong...Is New 90 Day High Low • Oct 08New 90-day high: ₹367The company is up 54% from its price of ₹239 on 10 July 2020. The Indian market is up 9.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Pharmaceuticals industry, which is up 18% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₹286 per share.분석 기사 • Oct 01Does FDC (NSE:FDC) Deserve A Spot On Your Watchlist?Like a puppy chasing its tail, some new investors often chase 'the next big thing', even if that means buying 'story...분석 기사 • Sep 10Estimating The Fair Value Of FDC Limited (NSE:FDC)Today we'll do a simple run through of a valuation method used to estimate the attractiveness of FDC Limited (NSE:FDC...분석 기사 • Aug 20What Kind Of Shareholders Hold The Majority In FDC Limited's (NSE:FDC) Shares?A look at the shareholders of FDC Limited (NSE:FDC) can tell us which group is most powerful. Insiders often own a...분석 기사 • Jul 25What You Can Learn From FDC Limited's (NSE:FDC) P/EWhen close to half the companies in India have price-to-earnings ratios (or "P/E's") below 12x, you may consider FDC...분석 기사 • Jul 07Is FDC Limited's (NSE:FDC) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?FDC's's (NSE:FDC) stock is up by a considerable 23% over the past three months. Given that the market rewards strong...지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: FDC 의 배당금 지급은 지난 10 년 동안 휘발성이었습니다.배당금 증가: FDC 의 배당금 지급은 지난 10 년 동안 증가했습니다.배당 수익률 vs 시장FDC 배당 수익률 vs 시장FDC의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (FDC)1.3%시장 하위 25% (IN)0.3%시장 상위 25% (IN)1.5%업계 평균 (Pharmaceuticals)0.7%분석가 예측 (FDC) (최대 3년)n/a주목할만한 배당금: FDC 의 배당금( 1.34% )은 Indian 시장에서 배당금 지급자의 하위 25%( 0.3% )보다 높습니다.고배당: FDC 의 배당금( 1.34% )은 Indian 시장에서 배당금 지급자의 상위 25%( 1.47% )와 비교해 낮습니다.주주 대상 이익 배당수익 보장: 합리적으로 낮은 지불 비율 ( 37.6% )로 FDC 의 배당금 지급은 수익으로 충분히 충당됩니다.주주 현금 배당현금 흐름 범위: FDC 배당금을 지급하고 있지만 회사에는 잉여현금흐름이 없습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YIN 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/24 16:30종가2026/05/22 00:00수익2025/12/31연간 수익2025/03/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스FDC Limited는 2명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관null nullCentrum Broking LimitedKameswari V. S. ChavaliFirstCall Research
Upcoming Dividend • Nov 15Upcoming dividend of ₹5.00 per shareEligible shareholders must have bought the stock before 22 November 2024. Payment date: 06 December 2024. Payout ratio is a comfortable 26% and this is well supported by cash flows. Trailing yield: 2.0%. Within top quartile of Indian dividend payers (1.2%). Higher than average of industry peers (0.7%).
Reported Earnings • Feb 07Third quarter 2026 earnings released: EPS: ₹1.74 (vs ₹2.28 in 3Q 2025)Third quarter 2026 results: EPS: ₹1.74 (down from ₹2.28 in 3Q 2025). Revenue: ₹4.86b (up 4.6% from 3Q 2025). Net income: ₹283.0m (down 24% from 3Q 2025). Profit margin: 5.8% (down from 8.0% in 3Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has increased by 12% per year, which means it is tracking significantly ahead of earnings growth.
Reported Earnings • Nov 06Second quarter 2026 earnings releasedSecond quarter 2026 results: Revenue: ₹4.94b (down 3.9% from 2Q 2025). Net income: ₹283.7m (down 61% from 2Q 2025). Profit margin: 5.7% (down from 14% in 2Q 2025). The decrease in margin was primarily driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has only increased by 12% per year, which means it is significantly lagging earnings growth.
공시 • Oct 20+ 1 more updateFDC Limited Announces CFO ChangesFDC Limited informed Mr. Vijay Dharmadatt Bhatt has resigned from the position of Chief Financial Officer (CFO) of the Company in order to pursue better prospects. The Board of Directors, at its meeting held on October 17, 2025, noted and accepted his resignation. Mr. Vijay D. Bhatt will be relieved from the responsibility of CFO after the close of business hours on October 20, 2025. The company further informed that based on the recommendation of the Nomination and Remuneration Committee and the Audit Committee, the Board of Directors of the Company have at its meeting held on October 17, 2025, approved the appointment of Mr. Vishal Shah as the Chief Financial Officer with effect from 24th October, 2025. Mr. Vishal Shah has about 20 years of work experience with an established track record of handling diverse finance portfolios like Business Finance, Costing, Financial Reporting and Treasury in the pharmaceutical industry.
분석 기사 • Sep 19We Think FDC Limited's (NSE:FDC) CEO Compensation Looks FairKey Insights FDC to hold its Annual General Meeting on 25th of September Total pay for CEO Nandan Chandavarkar includes...
공시 • Aug 29+ 2 more updatesFDC Limited to Report Q2, 2026 Results on Nov 05, 2025FDC Limited announced that they will report Q2, 2026 results on Nov 05, 2025
공시 • Aug 26FDC Limited, Annual General Meeting, Sep 25, 2025FDC Limited, Annual General Meeting, Sep 25, 2025, at 10:00 Indian Standard Time.
Reported Earnings • Aug 08First quarter 2026 earnings released: EPS: ₹7.45 (vs ₹7.31 in 1Q 2025)First quarter 2026 results: EPS: ₹7.45 (up from ₹7.31 in 1Q 2025). Revenue: ₹6.84b (up 7.2% from 1Q 2025). Net income: ₹1.21b (up 1.9% from 1Q 2025). Profit margin: 18% (in line with 1Q 2025). Over the last 3 years on average, earnings per share has increased by 18% per year whereas the company’s share price has increased by 21% per year.
공시 • Aug 02FDC Limited to Report Q1, 2026 Results on Aug 07, 2025FDC Limited announced that they will report Q1, 2026 results on Aug 07, 2025
분석 기사 • Jul 01A Look At The Fair Value Of FDC Limited (NSE:FDC)Key Insights Using the 2 Stage Free Cash Flow to Equity, FDC fair value estimate is ₹506 Current share price of ₹488...
분석 기사 • May 31FDC Limited's (NSE:FDC) Price Is Out Of Tune With EarningsThere wouldn't be many who think FDC Limited's ( NSE:FDC ) price-to-earnings (or "P/E") ratio of 26.7x is worth a...
Reported Earnings • May 29Full year 2025 earnings released: EPS: ₹16.39 (vs ₹18.59 in FY 2024)Full year 2025 results: EPS: ₹16.39 (down from ₹18.59 in FY 2024). Revenue: ₹22.0b (up 13% from FY 2024). Net income: ₹2.67b (down 13% from FY 2024). Profit margin: 12% (down from 16% in FY 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 19% per year whereas the company’s share price has increased by 21% per year.
공시 • May 22FDC Limited to Report Q4, 2025 Results on May 28, 2025FDC Limited announced that they will report Q4, 2025 results on May 28, 2025
Reported Earnings • Feb 14Third quarter 2025 earnings released: EPS: ₹2.28 (vs ₹4.86 in 3Q 2024)Third quarter 2025 results: EPS: ₹2.28 (down from ₹4.86 in 3Q 2024). Revenue: ₹4.64b (up 1.3% from 3Q 2024). Net income: ₹370.4m (down 53% from 3Q 2024). Profit margin: 8.0% (down from 17% in 3Q 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth.
Buy Or Sell Opportunity • Feb 10Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 7.6% to ₹461. The fair value is estimated to be ₹586, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 14%.
공시 • Feb 07FDC Limited to Report Q3, 2025 Results on Feb 12, 2025FDC Limited announced that they will report Q3, 2025 results on Feb 12, 2025
Buy Or Sell Opportunity • Jan 22Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 9.9% to ₹466. The fair value is estimated to be ₹586, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 14%.
공시 • Dec 19FDC Limited Receives Final Approval from US FDA for the Company's Abbreviated New Drug Application for Cefixime 400 mg TabletsFDC Limited announced that the Company has received final approval from US FDA for the Company's Abbreviated New Drug Application (ANDA) for Cefixime 400 mg Tablets.
Upcoming Dividend • Nov 15Upcoming dividend of ₹5.00 per shareEligible shareholders must have bought the stock before 22 November 2024. Payment date: 06 December 2024. Payout ratio is a comfortable 26% and this is well supported by cash flows. Trailing yield: 2.0%. Within top quartile of Indian dividend payers (1.2%). Higher than average of industry peers (0.7%).
분석 기사 • Nov 08Estimating The Fair Value Of FDC Limited (NSE:FDC)Key Insights FDC's estimated fair value is ₹583 based on 2 Stage Free Cash Flow to Equity FDC's ₹519 share price...
Reported Earnings • Nov 07Second quarter 2025 earnings released: EPS: ₹4.43 (vs ₹4.22 in 2Q 2024)Second quarter 2025 results: EPS: ₹4.43 (up from ₹4.22 in 2Q 2024). Revenue: ₹5.49b (up 13% from 2Q 2024). Net income: ₹720.4m (up 3.2% from 2Q 2024). Profit margin: 13% (down from 14% in 2Q 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 14% per year whereas the company’s share price has increased by 18% per year.
공시 • Oct 29FDC Limited to Report Q2, 2025 Results on Nov 06, 2024FDC Limited announced that they will report Q2, 2025 results on Nov 06, 2024
분석 기사 • Sep 20Why We Think FDC Limited's (NSE:FDC) CEO Compensation Is Not Excessive At AllKey Insights FDC will host its Annual General Meeting on 26th of September Total pay for CEO Nandan Chandavarkar...
분석 기사 • Sep 13There's Reason For Concern Over FDC Limited's (NSE:FDC) Massive 30% Price JumpThe FDC Limited ( NSE:FDC ) share price has done very well over the last month, posting an excellent gain of 30...
공시 • Sep 06FDC Limited Announces Cessation of CA Swati Sandesh Mayekar as Non-Independent DirectorFDC Limited announced that CA. Swati Sandesh Mayekar Non-Executive Independent Director of the Company have completed her tenure viz. second term of five (5) consecutive years on September 05, 2024 Consequently, she ceases to be the Independent Director of the company, accordingly she also ceases to be the member of various Board committees with effect from 06 September 2024.
공시 • Aug 28FDC Limited, Annual General Meeting, Sep 26, 2024FDC Limited, Annual General Meeting, Sep 26, 2024, at 10:00 Indian Standard Time.
분석 기사 • Aug 27Here's Why We Think FDC (NSE:FDC) Might Deserve Your Attention TodayFor beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
Reported Earnings • Aug 08First quarter 2025 earnings released: EPS: ₹7.31 (vs ₹6.62 in 1Q 2024)First quarter 2025 results: EPS: ₹7.31 (up from ₹6.62 in 1Q 2024). Revenue: ₹6.67b (up 24% from 1Q 2024). Net income: ₹1.19b (up 8.3% from 1Q 2024). Profit margin: 18% (down from 21% in 1Q 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 6% per year whereas the company’s share price has increased by 11% per year.
공시 • Jul 26FDC Limited to Report Q1, 2025 Results on Aug 07, 2024FDC Limited announced that they will report Q1, 2025 results on Aug 07, 2024
분석 기사 • Jul 04There Is A Reason FDC Limited's (NSE:FDC) Price Is UndemandingFDC Limited's ( NSE:FDC ) price-to-earnings (or "P/E") ratio of 26.5x might make it look like a buy right now compared...
Reported Earnings • May 30Full year 2024 earnings released: EPS: ₹18.58 (vs ₹11.67 in FY 2023)Full year 2024 results: EPS: ₹18.58 (up from ₹11.67 in FY 2023). Revenue: ₹20.4b (up 15% from FY 2023). Net income: ₹3.05b (up 57% from FY 2023). Profit margin: 15% (up from 11% in FY 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 2% per year but the company’s share price has increased by 11% per year, which means it is well ahead of earnings.
공시 • May 03FDC Limited Announces Board Completion of Tenure of Independent DirectorsFDC Limited announced that took note of the Completion of tenure of Independent Directors of the Company, namely, Ms. Usha Athreya Chandrasekhar and Mr. Melarkode Ganesan Parameswaran on May 9, 2024.
분석 기사 • Mar 02FDC Limited's (NSE:FDC) Price Is Right But Growth Is LackingWhen close to half the companies in India have price-to-earnings ratios (or "P/E's") above 32x, you may consider FDC...
Reported Earnings • Feb 08Third quarter 2024 earnings released: EPS: ₹4.86 (vs ₹2.45 in 3Q 2023)Third quarter 2024 results: EPS: ₹4.86 (up from ₹2.45 in 3Q 2023). Revenue: ₹4.83b (up 18% from 3Q 2023). Net income: ₹792.3m (up 95% from 3Q 2023). Profit margin: 16% (up from 10.0% in 3Q 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 9% per year but the company’s share price has increased by 16% per year, which means it is well ahead of earnings.
Reported Earnings • Nov 09Second quarter 2024 earnings released: EPS: ₹4.22 (vs ₹3.10 in 2Q 2023)Second quarter 2024 results: EPS: ₹4.22 (up from ₹3.10 in 2Q 2023). Revenue: ₹5.14b (up 15% from 2Q 2023). Net income: ₹698.2m (up 35% from 2Q 2023). Profit margin: 14% (up from 12% in 2Q 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 16% per year but the company’s share price has increased by 5% per year, which means it is well ahead of earnings.
분석 기사 • Sep 21Here's Why FDC Limited's (NSE:FDC) CEO May Have Their Pay Bumped UpKey Insights FDC to hold its Annual General Meeting on 27th of September CEO Nandan Chandavarkar's total compensation...
분석 기사 • Sep 15FDC (NSE:FDC) Seems To Use Debt Quite SensiblySome say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
공시 • Sep 05+ 2 more updatesFDC Limited to Report Fiscal Year 2024 Results on May 29, 2024FDC Limited announced that they will report fiscal year 2024 results on May 29, 2024
공시 • Aug 31FDC Limited, Annual General Meeting, Sep 27, 2023FDC Limited, Annual General Meeting, Sep 27, 2023, at 10:00 Indian Standard Time.
공시 • Aug 10+ 1 more updateFDC Limited (BSE:531599) agreed to acquire remaining 7% stake in Fair Deal Corporation Pharmaceutical SA (Pty) Ltd. from other existing shareholders.FDC Limited (BSE:531599) agreed to acquire remaining 7% stake in Fair Deal Corporation Pharmaceutical SA (Pty) Ltd. from other existing shareholders on July 13, 2023. The consideration for this transaction will be paid in cash with settlement of their existing outstanding loan with interest. Post completion of this transaction Fair Deal Corporation Pharmaceutical SA (Pty) Ltd will become the wholly owned subsidiary of FDC Limited. Fair Deal Corporation Pharmaceutical SA (Pty) Ltd generated the revenue of ZAR 11.9 million for the year ended March 31, 2023. The transaction has been approved by the Audit Committee and Board of Directors of FDC Limited. The deal is subject to necessary approvals and regulatory compliances.
New Risk • Aug 10New major risk - Revenue and earnings growthEarnings have declined by 1.1% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. This is currently the only risk that has been identified for the company.
Reported Earnings • Aug 10First quarter 2024 earnings released: EPS: ₹6.62 (vs ₹4.23 in 1Q 2023)First quarter 2024 results: EPS: ₹6.62 (up from ₹4.23 in 1Q 2023). Revenue: ₹5.66b (up 14% from 1Q 2023). Net income: ₹1.10b (up 55% from 1Q 2023). Profit margin: 19% (up from 14% in 1Q 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 18% per year but the company’s share price has increased by 8% per year, which means it is well ahead of earnings.
공시 • Aug 03FDC Limited to Report Q1, 2024 Results on Aug 09, 2023FDC Limited announced that they will report Q1, 2024 results on Aug 09, 2023
Reported Earnings • May 30Full year 2023 earnings released: EPS: ₹11.66 (vs ₹12.82 in FY 2022)Full year 2023 results: EPS: ₹11.66 (down from ₹12.82 in FY 2022). Revenue: ₹18.3b (up 20% from FY 2022). Net income: ₹1.94b (down 10% from FY 2022). Profit margin: 11% (down from 14% in FY 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 16% per year but the company’s share price has increased by 5% per year, which means it is well ahead of earnings.
Reported Earnings • Feb 10Third quarter 2023 earnings released: EPS: ₹2.45 (vs ₹2.11 in 3Q 2022)Third quarter 2023 results: EPS: ₹2.45 (up from ₹2.11 in 3Q 2022). Revenue: ₹4.28b (up 25% from 3Q 2022). Net income: ₹407.5m (up 14% from 3Q 2022). Profit margin: 9.5% (in line with 3Q 2022). Revenue is forecast to grow 21% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Pharmaceuticals industry in India. Over the last 3 years on average, earnings per share has fallen by 11% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings.
공시 • Feb 01FDC Limited to Report Q3, 2023 Results on Feb 09, 2023FDC Limited announced that they will report Q3, 2023 results on Feb 09, 2023
Reported Earnings • Nov 18Second quarter 2023 earnings released: EPS: ₹3.10 (vs ₹4.28 in 2Q 2022)Second quarter 2023 results: EPS: ₹3.10 (down from ₹4.28 in 2Q 2022). Revenue: ₹4.45b (up 12% from 2Q 2022). Net income: ₹518.4m (down 28% from 2Q 2022). Profit margin: 12% (down from 18% in 2Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 20% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Pharmaceuticals industry in India. Over the last 3 years on average, earnings per share has fallen by 3% per year but the company’s share price has increased by 14% per year, which means it is well ahead of earnings.
Price Target Changed • Nov 16Price target increased to ₹375Up from ₹350, the current price target is provided by 1 analyst. New target price is 32% above last closing price of ₹285. Stock is down 3.3% over the past year. The company is forecast to post earnings per share of ₹20.60 for next year compared to ₹12.82 last year.
분석 기사 • Sep 16Here's Why FDC Limited's (NSE:FDC) CEO Compensation Is The Least Of Shareholders' ConcernsCEO Nandan Chandavarkar has done a decent job of delivering relatively good performance at FDC Limited ( NSE:FDC...
공시 • Aug 30FDC Limited to Report Q4, 2023 Results on May 23, 2023FDC Limited announced that they will report Q4, 2023 results on May 23, 2023
Reported Earnings • Aug 05First quarter 2023 earnings released: EPS: ₹4.23 (vs ₹5.80 in 1Q 2022)First quarter 2023 results: EPS: ₹4.23 (down from ₹5.80 in 1Q 2022). Revenue: ₹5.14b (up 15% from 1Q 2022). Net income: ₹707.4m (down 28% from 1Q 2022). Profit margin: 14% (down from 22% in 1Q 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has increased by 18% per year, which means it is tracking significantly ahead of earnings growth.
Recent Insider Transactions • Jun 11Board Member recently bought ₹912k worth of stockOn the 8th of June, Melarkode Parameswaran bought around 4k shares on-market at roughly ₹247 per share. This was the largest purchase by an insider in the last 3 months. This was the only on-market transaction from insiders over the last 12 months.
Board Change • Jun 02Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 7 experienced directors. 3 highly experienced directors. Additional Non-Executive & Independent Director Ambi Parameswaran was the last director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.
Reported Earnings • May 27Full year 2022 earnings: EPS and revenues miss analyst expectationsFull year 2022 results: EPS: ₹12.81 (down from ₹17.73 in FY 2021). Net income: ₹2.16b (down 28% from FY 2021). Revenue missed analyst estimates by 3.1%. Earnings per share (EPS) also missed analyst estimates by 27%. Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has only increased by 8% per year, which means it is significantly lagging earnings growth.
분석 기사 • May 13A Look At The Intrinsic Value Of FDC Limited (NSE:FDC)In this article we are going to estimate the intrinsic value of FDC Limited ( NSE:FDC ) by projecting its future cash...
Price Target Changed • Apr 27Price target decreased to ₹415Down from ₹460, the current price target is provided by 1 analyst. New target price is 52% above last closing price of ₹273. Stock is down 12% over the past year. The company is forecast to post earnings per share of ₹17.60 for next year compared to ₹17.73 last year.
Reported Earnings • Feb 10Third quarter 2022 earnings: EPS and revenues miss analyst expectationsThird quarter 2022 results: EPS: ₹2.11 (down from ₹4.45 in 3Q 2021). Revenue: ₹3.55b (up 4.2% from 3Q 2021). Net income: ₹356.9m (down 53% from 3Q 2021). Profit margin: 10% (down from 22% in 3Q 2021). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 9.5%. Earnings per share (EPS) also missed analyst estimates by 7.7%. Over the next year, revenue is forecast to grow 22%, compared to a 13% growth forecast for the industry in India. Over the last 3 years on average, earnings per share has increased by 20% per year whereas the company’s share price has increased by 24% per year.
분석 기사 • Nov 18Weak Statutory Earnings May Not Tell The Whole Story For FDC (NSE:FDC)The subdued market reaction suggests that FDC Limited's ( NSE:FDC ) recent earnings didn't contain any surprises. We...
Reported Earnings • Nov 16Second quarter 2022 earnings released: EPS ₹4.28 (vs ₹5.15 in 2Q 2021)The company reported a soft second quarter result with weaker earnings and profit margins, although revenues improved. Second quarter 2022 results: Revenue: ₹3.98b (up 7.1% from 2Q 2021). Net income: ₹724.0m (down 18% from 2Q 2021). Profit margin: 18% (down from 24% in 2Q 2021). The decrease in margin was driven by higher expenses.
Price Target Changed • Nov 16Price target decreased to ₹415Down from ₹470, the current price target is provided by 1 analyst. New target price is 40% above last closing price of ₹297. Stock is down 8.7% over the past year. The company is forecast to post earnings per share of ₹20.80 for next year compared to ₹17.73 last year.
분석 기사 • Aug 20Here's Why I Think FDC (NSE:FDC) Is An Interesting StockIt's only natural that many investors, especially those who are new to the game, prefer to buy shares in 'sexy' stocks...
Reported Earnings • Aug 18First quarter 2022 earnings released: EPS ₹5.80 (vs ₹5.36 in 1Q 2021)The company reported a solid first quarter result with improved earnings and revenues, although profit margins were weaker. First quarter 2022 results: Revenue: ₹4.47b (up 45% from 1Q 2021). Net income: ₹978.7m (up 6.7% from 1Q 2021). Profit margin: 22% (down from 30% in 1Q 2021). The decrease in margin was driven by higher expenses.
Valuation Update With 7 Day Price Move • Jun 16Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₹394, the stock trades at a forward P/E ratio of 18x. Average forward P/E is 26x in the Pharmaceuticals industry in India. Total returns to shareholders of 63% over the past three years.
분석 기사 • May 29FDC Limited (NSE:FDC) Just Recorded An Earnings Miss And Analysts Are Updating Their NumbersFDC Limited ( NSE:FDC ) missed earnings with its latest full-year results, disappointing overly-optimistic forecasts...
Reported Earnings • May 28Full year 2021 earnings released: EPS ₹17.72 (vs ₹13.94 in FY 2020)The company reported a decent full year result with improved earnings and profit margins, although revenues were flat. Full year 2021 results: Revenue: ₹13.3b (flat on FY 2020). Net income: ₹3.01b (up 26% from FY 2020). Profit margin: 23% (up from 18% in FY 2020). Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has only increased by 12% per year, which means it is significantly lagging earnings growth.
분석 기사 • Apr 30Here's Why We Think FDC (NSE:FDC) Is Well Worth WatchingFor beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
분석 기사 • Mar 11What Percentage Of FDC Limited (NSE:FDC) Shares Do Insiders Own?The big shareholder groups in FDC Limited ( NSE:FDC ) have power over the company. Generally speaking, as a company...
분석 기사 • Feb 21If You Had Bought FDC (NSE:FDC) Shares Five Years Ago You'd Have Earned 63% ReturnsIt hasn't been the best quarter for FDC Limited ( NSE:FDC ) shareholders, since the share price has fallen 10% in that...
Price Target Changed • Feb 10Price target raised to ₹470Up from ₹425, the current price target is an average from 2 analysts. The new target price is 69% above the current share price of ₹278. As of last close, the stock is up 10% over the past year.
분석 기사 • Feb 06Declining Stock and Solid Fundamentals: Is The Market Wrong About FDC Limited (NSE:FDC)?It is hard to get excited after looking at FDC's (NSE:FDC) recent performance, when its stock has declined 13% over the...
Reported Earnings • Feb 05Third quarter 2021 earnings released: EPS ₹4.47 (vs ₹4.31 in 3Q 2020)The company reported a solid third quarter result with improved earnings and revenues, although profit margins were weaker. Third quarter 2021 results: Revenue: ₹3.75b (up 17% from 3Q 2020). Net income: ₹752.5m (up 1.5% from 3Q 2020). Profit margin: 20% (down from 23% in 3Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 27% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.
Is New 90 Day High Low • Feb 05New 90-day low: ₹288The company is down 13% from its price of ₹332 on 06 November 2020. The Indian market is up 23% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Pharmaceuticals industry, which is up 9.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₹147 per share.
Is New 90 Day High Low • Jan 21New 90-day low: ₹312The company is down 10.0% from its price of ₹347 on 23 October 2020. The Indian market is up 24% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Pharmaceuticals industry, which is up 10.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₹89.28 per share.
분석 기사 • Jan 19With EPS Growth And More, FDC (NSE:FDC) Is InterestingFor beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
분석 기사 • Dec 29FDC Limited (NSE:FDC) Has Got What It Takes To Be An Attractive Dividend StockIs FDC Limited ( NSE:FDC ) a good dividend stock? How can we tell? Dividend paying companies with growing earnings can...
분석 기사 • Dec 08Could The FDC Limited (NSE:FDC) Ownership Structure Tell Us Something Useful?The big shareholder groups in FDC Limited ( NSE:FDC ) have power over the company. Institutions will often hold stock...
분석 기사 • Nov 12The FDC (NSE:FDC) Share Price Has Gained 79% And Shareholders Are Hoping For MoreThe simplest way to invest in stocks is to buy exchange traded funds. But investors can boost returns by picking...
Reported Earnings • Nov 10Second quarter 2021 earnings released: EPS ₹5.15The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: ₹3.90b (up 13% from 2Q 2020). Net income: ₹880.8m (up 63% from 2Q 2020). Profit margin: 23% (up from 16% in 2Q 2020). The increase in margin was driven by higher revenue.
Analyst Estimate Surprise Post Earnings • Nov 10Revenue and earnings beat expectationsRevenue exceeded analyst estimates by 14%. Earnings per share (EPS) also surpassed analyst estimates by 22%. Over the next year, revenue is forecast to grow 16%, compared to a 12% growth forecast for the Pharmaceuticals industry in India.
분석 기사 • Oct 22Is FDC Limited's (NSE:FDC) Latest Stock Performance A Reflection Of Its Financial Health?FDC's (NSE:FDC) stock is up by a considerable 27% over the past three months. Given that the market rewards strong...
Is New 90 Day High Low • Oct 08New 90-day high: ₹367The company is up 54% from its price of ₹239 on 10 July 2020. The Indian market is up 9.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Pharmaceuticals industry, which is up 18% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₹286 per share.
분석 기사 • Oct 01Does FDC (NSE:FDC) Deserve A Spot On Your Watchlist?Like a puppy chasing its tail, some new investors often chase 'the next big thing', even if that means buying 'story...
분석 기사 • Sep 10Estimating The Fair Value Of FDC Limited (NSE:FDC)Today we'll do a simple run through of a valuation method used to estimate the attractiveness of FDC Limited (NSE:FDC...
분석 기사 • Aug 20What Kind Of Shareholders Hold The Majority In FDC Limited's (NSE:FDC) Shares?A look at the shareholders of FDC Limited (NSE:FDC) can tell us which group is most powerful. Insiders often own a...
분석 기사 • Jul 25What You Can Learn From FDC Limited's (NSE:FDC) P/EWhen close to half the companies in India have price-to-earnings ratios (or "P/E's") below 12x, you may consider FDC...
분석 기사 • Jul 07Is FDC Limited's (NSE:FDC) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?FDC's's (NSE:FDC) stock is up by a considerable 23% over the past three months. Given that the market rewards strong...